The Thesis
RSI Snap-Back is built on a simple, well-worn premise: large-cap tech names tend to snap back sharply after short-term momentum extremes. The strategy buys the most oversold members of the Mag-7 universe — AAPL, MSFT, NVDA, GOOGL, AMZN, META, and TSLA — when their RSI falls below 35, and exits when RSI climbs above 70. A hard four-slot book caps concurrent positions, which is meant to enforce discipline and limit how much drawdown the strategy can accumulate at once.
It's a clean, legible idea. Mean reversion on liquid mega-caps is one of the more defensible corners of the factor world, and the tight book is a sensible guardrail against over-concentration.
Recent Activity
Here's where the update gets interesting: RSI Snap-Back has done nothing lately. The last six scheduled runs — from July 23 through July 30 — each report 0 executed, 0 rejected, with the book sitting entirely in cash at $10,000. No positions, no rotations, no new signals.
That isn't a malfunction; it's the strategy behaving as designed. With no Mag-7 name pushing RSI below 35, there's simply nothing to buy. A mean-reversion system that only acts on genuine oversold extremes will, by construction, spend long stretches idle. Patience is the feature. The flip side is opportunity cost: while the book holds cash, it earns nothing, and a run of calm or steadily rising markets can leave it sidelined for weeks.
Backtest & Validation
Over a 451-day backtest, RSI Snap-Back returned 20.95% (final equity $12,095), an 11.21% CAGR, with a 66.67% win rate across 37 trades. The hit rate is genuinely strong, and two-thirds winners on a reversion strategy suggests the entry logic is finding real dislocations rather than catching falling knives.
The risk picture is more sobering. The Sharpe of 0.61 is modest — respectable but not the kind of risk-adjusted profile that inspires leverage. More concerning is the 23.73% max drawdown, which nearly erases a full year of returns at the trough. For a strategy whose selling point is a tight, disciplined book, giving back almost a quarter of capital is a meaningful dent in the pitch. Turnover of 773% is also high, implying frequent rotation; fees were a trivial $37 here, but in a higher-cost or thinner-liquidity setting that churn would bite harder.
The most important caveat: validation is null. There is no out-of-sample or walk-forward result reported, so the 20.95% figure rests entirely on a single in-sample backtest. On a strategy this parameter-sensitive — the RSI thresholds and the four-slot cap are both tunable — that absence is the single biggest open question.
Verdict
RSI Snap-Back is a coherent, disciplined idea with an encouraging win rate and a positive live status. But the modest Sharpe, the near-24% drawdown, and — above all — the missing validation mean it should be read as a promising hypothesis rather than a proven edge. The current cash-heavy idle stretch is a fair reminder that this strategy is only as good as the extremes the market hands it.